Back
Novo Nordisk AS Stock Predictions

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
NVO
Novo Nordisk AS
Last Price:
$68.21
Seasonality Move:
4.1%
7 Day Trial
ALL ACCESS PASS
$
7
Novo Nordisk AS Stock Forecast
-
Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 18.7% based on the past 44 years of stock performance.
-
Novo Nordisk AS has risen higher in 34 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.27%
-
Is Novo Nordisk AS Stock Undervalued?The current Novo Nordisk AS [NVO] share price is $67.02. The Score for NVO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk AS Stock Go Up Next Year?
-
Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 18.7% based on the past 44 years of stock performance.
Novo Nordisk AS Stock Rating
Sell
49
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS overpriced?
-
Novo Nordisk AS has risen higher in 34 of those 44 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.27%
Novo Nordisk AS Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
148.15
52-Week Low:
57.00
Prediction Charts
Market Cap:
297.8B
Price in USD:
67.02
Volume:
11.1M
Beta:
0.51
Technical Analysis
SMA50:
68.12
SMA100:
76.74
SMA200:
98.04
52-Wk Change:
-49.18%
Stock Predictions
-
Is Novo Nordisk AS stock public?Yes, Novo Nordisk AS is a publicly traded company.
-
What is the Novo Nordisk AS stock quote today?The Novo Nordisk AS stock price is 67.02 USD today.
-
How to buy Novo Nordisk AS stock online?You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 66.48 | 66.45 | 66.64 | 65.40 |
May-1 | 68.81 | 65.60 | 68.83 | 64.18 |
May-2 | 69.75 | 69.23 | 69.86 | 68.53 |
May-5 | 69.17 | 69.12 | 69.79 | 68.89 |
May-6 | 67.96 | 66.29 | 68.12 | 65.99 |
May-7 | 69.35 | 67.55 | 69.67 | 66.82 |
May-8 | 65.91 | 64.85 | 65.96 | 64.40 |
May-9 | 67.00 | 65.77 | 67.44 | 65.59 |
May-12 | 64.09 | 67.74 | 67.75 | 64.04 |
May-13 | 66.61 | 65.40 | 66.63 | 64.95 |
May-14 | 66.50 | 64.41 | 66.83 | 64.09 |
May-15 | 65.16 | 66.15 | 66.30 | 64.78 |
May-16 | 64.40 | 64.37 | 64.70 | 63.13 |
May-19 | 65.32 | 67.02 | 67.03 | 64.87 |
Novo Nordisk AS Earnings
Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk AS Forecast Revenue Growth
Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.15 per share, an increase this year of $0.86 per share, and an increase next year of $0.68 per share.
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.